loading...| Preferred Name | Meropenem | |
| Synonyms |
|
|
| Definitions |
A broad-spectrum carbapenem with antibacterial properties, synthetic Meropenem inhibits cell wall synthesis in gram-positive and gram-negative bacteria. It penetrates cell walls and binds to penicillin-binding protein targets. Meropenem acts against aerobes and anaerobes including Klebsiella, E. coli, Enterococcus, Clostridium sp.. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1160 |
|
| Accepted_Therapeutic_Use_For |
Gram positive and gram-negative intra-abdominal infections; bacterial meningitis |
|
| CAS_Registry |
119478-56-7 |
|
| CHEBI_ID |
CHEBI:6770 |
|
| Chemical_Formula |
C17H25N3O5S.3H2O |
|
| code |
C1160 |
|
| Contributing_Source |
FDA |
|
| definition |
A broad-spectrum carbapenem with antibacterial properties, synthetic Meropenem inhibits cell wall synthesis in gram-positive and gram-negative bacteria. It penetrates cell walls and binds to penicillin-binding protein targets. Meropenem acts against aerobes and anaerobes including Klebsiella, E. coli, Enterococcus, Clostridium sp.. (NCI04) |
|
| FDA_UNII_Code |
FV9J3JU8B1 |
|
| in_subset | ||
| label |
Meropenem |
|
| Legacy Concept Name |
Meropenem |
|
| NCI_Drug_Dictionary_ID |
41899 |
|
| PDQ_Closed_Trial_Search_ID |
41899 |
|
| PDQ_Open_Trial_Search_ID |
41899 |
|
| Preferred_Name |
Meropenem |
|
| prefixIRI |
NCIT:C1160 |
|
| prefLabel |
Meropenem |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance Antibiotic |
|
| UMLS_CUI |
C0066005 |
|
| subClassOf |